Insider Transactions in Q2 2023 at Krystal Biotech, Inc. (KRYS)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 09
2023
|
Andrew C. Orth Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
12,500
-70.92%
|
$1,600,000
$128.91 P/Share
|
|
Jun 09
2023
|
Andrew C. Orth Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+49.8%
|
$787,500
$63.55 P/Share
|
|
Jun 09
2023
|
Daniel Janney Director |
SELL
Open market or private sale
|
Indirect |
18,935
-5.24%
|
$2,423,680
$128.89 P/Share
|
|
Jun 08
2023
|
Daniel Janney Director |
SELL
Open market or private sale
|
Indirect |
31,065
-3.58%
|
$3,976,320
$128.25 P/Share
|
|
May 31
2023
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.51%
|
$2,900,000
$116.8 P/Share
|
|
May 31
2023
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-0.49%
|
$2,900,000
$116.85 P/Share
|
|
May 31
2023
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
25,000
-0.49%
|
$2,900,000
$116.85 P/Share
|
|
May 31
2023
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Direct |
25,000
-0.51%
|
$2,900,000
$116.8 P/Share
|
|
May 22
2023
|
Kathryn Romano Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
25,000
-22.02%
|
$2,700,000
$108.27 P/Share
|
|
May 22
2023
|
Kathryn Romano Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+17.24%
|
$1,350,000
$54.14 P/Share
|
|
May 19
2023
|
Daniel Janney Director |
SELL
Open market or private sale
|
Indirect |
50,000
-24.11%
|
$4,750,000
$95.02 P/Share
|
|
May 19
2023
|
Kathryn Romano Chief Accounting Officer |
SELL
Open market or private sale
|
Direct |
28,428
-36.41%
|
$2,700,660
$95.06 P/Share
|
|
May 19
2023
|
Kathryn Romano Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+30.5%
|
$1,300,000
$52.26 P/Share
|
|
May 09
2023
|
Daniel Janney Director |
SELL
Open market or private sale
|
Indirect |
17,100
-7.62%
|
$1,539,000
$90.74 P/Share
|
|
Apr 19
2023
|
Daniel Janney Director |
SELL
Open market or private sale
|
Indirect |
7,900
-3.4%
|
$711,000
$90.32 P/Share
|
|
Apr 17
2023
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Indirect |
25,000
-0.3%
|
$2,175,000
$87.46 P/Share
|
|
Apr 17
2023
|
Krish S Krishnan President and CEO |
SELL
Open market or private sale
|
Direct |
25,000
-0.29%
|
$2,175,000
$87.46 P/Share
|
|
Apr 17
2023
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Indirect |
25,000
-0.29%
|
$2,175,000
$87.46 P/Share
|
|
Apr 17
2023
|
Suma Krishnan President, R&D |
SELL
Open market or private sale
|
Direct |
25,000
-0.3%
|
$2,175,000
$87.46 P/Share
|